Literaturliste 2006

Siener R, Schade N, Nicolay C, von Unruh GE, Hesse A.
The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent
calcium oxalate stone patients.
J Urol. 2005 May;173(5):1601-5.
Siewert E, Weyers W, Dietrich CG, Geier A, Lammert F, Matern S.
Cutaneous mucinosis and skin necrosis complicates interferon alfacon-1 (consensus
interferon) treatment of chronic hepatitis C.
Eur J Med Res. 2005 Feb 28;10(2):63-7.
Soriano V, Puoti M, Bonacini M, Brook G, Cargnel A, Rockstroh J, Thio C,
Benhamou Y.
Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an
HIV-HBV International Panel.
AIDS. 2005 Feb 18;19(3):221-40. Review. No abstract available. Erratum in: AIDS. 2005
Mar 24;19(6):3 p following 640.
Stubiger G, Marchetti M, Nagano M, Grimm R, Gmeiner G, Reichel C, Allmaier G.
Characterization of N- and O-glycopeptides of recombinant human erythropoietins as
potential biomarkers for doping analysis by means of microscale sample purification
combined with MALDI-TOF and quadrupole IT/RTOF mass spectrometry.
J Sep Sci. 2005 Sep;28(14):1764-78.
Stubiger G, Marchetti M, Nagano M, Reichel C, Gmeiner G, Allmaier G.
Characterisation of intact recombinant human erythropoietins applied in doping by
means of planar gel electrophoretic techniques and matrix-assisted laser
desorption/ionisation linear time-of-flight mass spectrometry.
Rapid Commun Mass Spectrom. 2005;19(5):728-42.
Tasci S, Burghard A, Schäfer H, Rabe C, Ewig S, Lüderitz B.
[Long-term outcome of intrapleural fibrinolytic therapy via small-bore catheter drainage in
the management of complicated parapneumonic effusion and empyema-a case series]
Med Klin (Munich). 2005 Apr 15;100(4):181-5. German.
Terjung B, Spengler U.
Role of auto-antibodies for the diagnosis of chronic cholestatic liver diseases.
Clin Rev Allergy Immunol. 2005 Apr;28(2):115-33. Review.
Vogel M, Voigt E, Schäfer N, Goldmann G, Schwarz N, Kalff JC, Sauerbruch T,
Wolff M, Rockstroh JK, Spengler U.
Orthotopic liver transplantation in human immunodeficiency virus (HIV)-positive patients:
outcome of 7 patients from the Bonn cohort.
Liver Transpl. 2005 Dec;11(12):1515-21.
Vogel M, Rockstroh JK.
Safety of lopinavir/ritonavir for the treatment of HIV-infection.
Expert Opin Drug Saf. 2005 May;4(3):403-20.
Vogel M, Rockstroh JK.
[Therapy of hepatitis B and hepatitis C coinfection in HIV patients]
MMW Fortschr Med. 2005 Apr 25;147 Spec No 1:56-9. German.